share_log

Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth

Irwin Naturals, Numinus, Field Trip: Sector Analyst Compares Footprints, Cash, Organic Growth

歐文自然,Numinus,實地考察:部門分析師比較足跡,現金,有機增長
Benzinga Real-time News ·  2023/01/24 12:07
The Analyst
《分析師》
Analyst Pablo Zuanic from Cantor Fitzgerald kept an Overweight rating for Irwin Naturals (CSE:IWIN) (OTC:IWINF) but lowered its 12-month price target to US$6.00 (C$8.05) from US$6.20 "on adjusted estimates."
分析員巴勃羅·祖阿尼奇Fitzgerald對Irwin Naturals(CSE:IWIN)(場外交易代碼:IWINF)維持增持評級,但根據調整後的估計,將其12個月目標價從6.20美元下調至6.00美元(8.05加元)。
The Thesis
這篇論文是
Zuanic highlighted the "potential approval of various forms of psychedelics-assisted therapy, which should provide a boost for the mental health clinics sector (where stocks remain mostly under the radar)."
祖阿尼克強調説,“可能會批准各種形式的迷幻藥輔助治療,這應該會提振精神健康診所部門(該部門的股票大多仍不受關注)。”
Irwin Naturals remains focused on its "roll-up strategy" of the mental health clinics industry, but "it has pushed out targets (100 clinics by end of CY24 vs. CY23 before)," Zuanic said in his analyst note on Monday...
Irwin Naturals仍然專注於其心理健康診所行業的“彙總戰略”...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論